Seasonal modulation of post-resection breast cancer metastasis
- PMID: 17934872
- DOI: 10.1007/s10549-007-9780-8
Seasonal modulation of post-resection breast cancer metastasis
Abstract
Background: Human breast cancer incidence, histopathologic grade, invasiveness, and mortality risk vary significantly throughout each year. In order to better understand this seasonal cancer biology, we investigated the circannual pattern of post-resection breast cancer metastasis, under genetically and environmentally controlled conditions.
Methods: Over a span of 14 consecutive years, we conducted 22 similar experiments to investigate metastatic biology of breast cancer among 1,214 C3HeB/FeJ female mice. All mice were kept in temperature-controlled environment with 12 h light:12 h dark photoperiod, with food and water freely available, from birth until death. At 10-13 weeks of age, each mouse received 20,000 viable syngeneic mammary cancer cells subcutaneously and the tumor bearing leg was resected 10-12 days after tumor inoculation for potential cure. Once 10% of resected mice were found moribund, due to autopsy proven pulmonary metastases, all remaining mice were sacrificed and metastatic lung nodules were counted.
Results: The incidence of post-resection pulmonary metastasis was not randomly distributed throughout the year, but peaked prominently in Summer and Winter. Although tumor volume at resection was strongly associated with metastatic potential, a significantly higher probability of pulmonary metastasis was observed if surgery was performed in Summer and Winter, regardless of tumor volume at resection, compared to Spring and Fall.
Conclusion: These results support the likelihood that human breast cancer seasonality is real and of biological origin. There are implications of this cancer chronobiology for breast cancer prevention, screening, diagnosis, and treatment.
Similar articles
-
Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model.Cancer Gene Ther. 2008 Dec;15(12):776-86. doi: 10.1038/cgt.2008.43. Epub 2008 Jul 25. Cancer Gene Ther. 2008. PMID: 18654613
-
Vaticanol C, a novel resveratrol tetramer, reduces lymph node and lung metastases of mouse mammary carcinoma carrying p53 mutation.Cancer Chemother Pharmacol. 2007 Oct;60(5):681-91. doi: 10.1007/s00280-007-0414-y. Epub 2007 Jan 26. Cancer Chemother Pharmacol. 2007. PMID: 17256131
-
Discovery of candidate genes and pathways that may help explain fertility cycle stage dependent post-resection breast cancer outcome.Breast Cancer Res Treat. 2009 Nov;118(2):345-59. doi: 10.1007/s10549-008-0253-5. Breast Cancer Res Treat. 2009. PMID: 19051007
-
[Establishment of a whole-body visualization model of breast cancer with high hepatic metastatic potential in nude mice through serial passage in vivo].Nan Fang Yi Ke Da Xue Xue Bao. 2008 Jun;28(6):944-7. Nan Fang Yi Ke Da Xue Xue Bao. 2008. PMID: 18583234 Chinese.
-
Sex cycle modulates cancer growth.Breast Cancer Res Treat. 2005 May;91(1):95-102. doi: 10.1007/s10549-005-8269-6. Breast Cancer Res Treat. 2005. PMID: 15868436
Cited by
-
Differences in vitamin D status may account for unexplained disparities in cancer survival rates between African and white Americans.Dermatoendocrinol. 2012 Apr 1;4(2):85-94. doi: 10.4161/derm.19667. Dermatoendocrinol. 2012. PMID: 22928063 Free PMC article.
-
Efficacy of a new cancer treatment strategy based on eradication of tumor-initiating stem cells in a mouse model of Krebs-2 solid adenocarcinoma.Oncotarget. 2018 Jun 19;9(47):28486-28499. doi: 10.18632/oncotarget.25503. eCollection 2018 Jun 19. Oncotarget. 2018. PMID: 29983875 Free PMC article.
-
The synergistic antitumor effect of Karanahan technology and in situ vaccination using anti-OX40 antibodies.Oncol Res. 2025 Apr 18;33(5):1229-1248. doi: 10.32604/or.2025.059411. eCollection 2025. Oncol Res. 2025. PMID: 40296901 Free PMC article.
-
Seasonal variation influences outcomes following lung cancer resections.Eur J Cardiothorac Surg. 2011 Jul;40(1):83-90. doi: 10.1016/j.ejcts.2010.11.023. Epub 2010 Dec 18. Eur J Cardiothorac Surg. 2011. PMID: 21169031 Free PMC article.
-
Chronometric Administration of Cyclophosphamide and a Double-Stranded DNA-Mix at Interstrand Crosslinks Repair Timing, Called "Karanahan" Therapy, Is Highly Efficient in a Weakly Immunogenic Lewis Carcinoma Model.Pathol Oncol Res. 2022 May 27;28:1610180. doi: 10.3389/pore.2022.1610180. eCollection 2022. Pathol Oncol Res. 2022. PMID: 35693632 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical